He wouldn't respond. Coal price is down, no progress in PH-3 trial. So what has he got to say? Very inefficient management.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025